Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study

BACKGROUND

The severe acute respiratory syndrome Coronarovirus-2 associated still causes a significant number of deaths and hospitalizations mainly by the development of respiratory failure. We aim to validate lung ultrasound score in order to predict mortality and the severity of the clinical course related to the need of respiratory support.

METHODS

In this prospective multicenter hospital-based cohort study, all adult patients with diagnosis of SARS-CoV-2 infection, performed by real-time reverse transcription polymerase chain reaction were included. Upon admission, all patients underwent blood gas analysis and lung ultrasound by expert operators. The acquisition of ultrasound scan was performed on 12 peculiar anatomic landmarks of the chest. Lung ultrasound findings were classified according to a scoring method, ranging 0 to 3: Score 0: normal A-lines. Score 1: multiple separated B-lines. Score 2: coalescent B-lines, alteration of pleural line. Score 3: consolidation area.

RESULTS

One thousand and seven patients were included in statistical analysis (male 62.4 %, mean age 66.3). Oxygen support was needed in 811 (80.5 %) patients. The median ultrasound score was 24 and the risk of having more invasive respiratory support increased in relation to higher values score computed. Lung ultrasound score showed negative strong correlation (rho: -0.71) with the P/F ratio and a significant association with in-hospital mortality (OR 1.11, 95 %CI 1.07-1.14; p < 0.001), even after adjustment with the following variables (age, sex, P/F ratio, SpO2, lactate, hypertension, chronic renal failure, diabetes, and obesity).

CONCLUSIONS

The novelty of this research corroborates and validates the 12-field lung ultrasound score as tool for predicting mortality and severity clinical course in COVID-19 patients. Baseline lung ultrasound score was associated with in-hospital mortality and requirement of intensive respiratory support and predict the risk of IOT among COVID-19 patients.

Percutaneous ablation in perivascular-HCC: impact of liver parenchyma and characteristics of vascular structures on the outcomes

AIM

Percutaneous radiofrequency ablation (RFA) is a standard treatment for small-HCC (<3 cm). However, some features such as proximity to intrahepatic vascular structures (perivascular location) seem to be related to short- and long-term outcomes. The aims of the study were to investigate the features related to ablation success and local tumor progression (LTP) in patients submitted to percutaneous ablation for perivascular-HCC.

MATERIALS AND METHODS

From January 2010 to May 2021, 132 perivascular-HCC nodules ablated with US-guided single probe percutaneous RFA were retrospectively analyzed. Univariate analysis and multivariable Cox regression model were used to identify factors that were independently related to ablation success and LTP-free survival.

RESULTS

The overall ablation success rate was 71.9% (n=95). Morbidity and mortality rates were 4.0% and 0.0%. The features related to ablation success: nodule size (≤20 mm vs. >20 mm) (OR 2.442, p=0.031), major vascular structures diameter (3-5 mm vs ≥ 5 mm) (OR 2.167, p=0.037) and liver parenchyma (cirrhosis vs no-cirrhosis) (OR 2.373, p=0.033). The following features resulted independently related to better LTP-free survival: nodule size ≤20 mm (HR 2.802, p=0.003), proximity to glissonean pedicles (HR 1.677, p=0.028), and major vascular structure diameter <5 mm (HR 1.987, p=0.041).

CONCLUSIONS

Perivascular location confirmed to be a difficult and unfavorable indication for percutaneous ablation for HCC nodules. However, perivascular nodules not suitable for surgery with low-risk features (size <20 mm, proximity to glissonian pedicles and vascular diameter <5 mm) may be treated with RFA with satisfactory outcomes.

A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial

BACKGROUND

There is no consensus on the second-line treatment of patients with progressive high-grade neuroendocrine neoplasms (NENs G3) and large-cell lung neuroendocrine carcinoma. These patients generally have poor performance status and low tolerance to combination therapy. In this trial, we aim to evaluate the efficacy and safety of temozolomide given every other week in patients with advanced platinum-pretreated NENs G3.

PATIENTS AND METHODS

This trial is an open-label, non-randomized, phase II trial. Patients with platinum-pretreated metastatic neuroendocrine carcinoma were treated with 75 mg/m2/day of temozolomide for 7 days, followed by 7 days of no treatment (regimen one week on/one week off). The primary endpoint was the overall response rate. Secondary endpoints included progression-free survival (PFS), overall survival (OS), safety and tolerability. This study is registered with ClinicalTrials.gov, NCT04122911.

RESULTS

From 2017 to 2020, 38 patients were enrolled. Among the patients with determined Ki67, 12 out of 36 (33.3%) had a Ki67 index <55% and the remaining 24 out of 36 (66.6%) had an index ≥55%. Overall response rate was 18% (7/38), including one complete response and six partial responses. The median PFS was 5.86 months [95% confidence interval (CI) 4.8 months-not applicable) and the median OS was 12.1 months (95% CI 5.6-20.4 months). The 1-year PFS rate was 37%. No statistically significant difference in median PFS [hazard ratio 1.3 (95% CI 0.6-2.8); P = 0.44] and median OS [hazard ratio 1.1 (95% CI 0.5-2.4); P = 0.77] was observed among patients with Ki67 <55% versus ≥55%. Only G1-G2 adverse events were registered, the most common being G1 nausea, diarrhea and abdominal pain.

CONCLUSION

One week on/one week off temozolomide shows promising activity in patients with poorly differentiated NEN. The good safety profile confirmed the possibility of using this scheme in patients with poor performance status.

Toll-like receptor signalling via IRAK4 affects epithelial integrity and tightness through regulation of junctional tension

Toll-like receptors (TLRs) in mammalian systems are well known for their role in innate immunity. In addition, TLRs also fulfil crucial functions outside immunity, including the dorsoventral patterning function of the original Toll receptor in Drosophila and neurogenesis in mice. Recent discoveries in flies suggested key roles for TLRs in epithelial cells in patterning of junctional cytoskeletal activity. Here, we address the function of TLRs and the downstream key signal transduction component IRAK4 in human epithelial cells. Using differentiated human Caco-2 cells as a model for the intestinal epithelium, we show that these cells exhibit baseline TLR signalling, as revealed by p-IRAK4, and that blocking IRAK4 function leads to a loss of epithelial tightness involving key changes at tight and adherens junctions, such as a loss of epithelial tension and changes in junctional actomyosin. Changes upon IRAK-4 inhibition are conserved in human bronchial epithelial cells. Knockdown of IRAK4 and certain TLRs phenocopies the inhibitor treatment. These data suggest a model whereby TLR receptors near epithelial junctions might be involved in a continuous sensing of the epithelial state to promote epithelial tightness and integrity.

Homeostasis, injury, and recovery dynamics at multiple scales in a self-organizing mouse intestinal crypt

The maintenance of the functional integrity of the intestinal epithelium requires a tight coordination between cell production, migration, and shedding along the crypt-villus axis. Dysregulation of these processes may result in loss of the intestinal barrier and disease. With the aim of generating a more complete and integrated understanding of how the epithelium maintains homeostasis and recovers after injury, we have built a multi-scale agent-based model (ABM) of the mouse intestinal epithelium. We demonstrate that stable, self-organizing behaviour in the crypt emerges from the dynamic interaction of multiple signalling pathways, such as Wnt, Notch, BMP, ZNRF3/RNF43, and YAP-Hippo pathways, which regulate proliferation and differentiation, respond to environmental mechanical cues, form feedback mechanisms, and modulate the dynamics of the cell cycle protein network. The model recapitulates the crypt phenotype reported after persistent stem cell ablation and after the inhibition of the CDK1 cycle protein. Moreover, we simulated 5-fluorouracil (5-FU)-induced toxicity at multiple scales starting from DNA and RNA damage, which disrupts the cell cycle, cell signalling, proliferation, differentiation, and migration and leads to loss of barrier integrity. During recovery, our in silico crypt regenerates its structure in a self-organizing, dynamic fashion driven by dedifferentiation and enhanced by negative feedback loops. Thus, the model enables the simulation of xenobiotic-, in particular chemotherapy-, induced mechanisms of intestinal toxicity and epithelial recovery. Overall, we present a systems model able to simulate the disruption of molecular events and its impact across multiple levels of epithelial organization and demonstrate its application to epithelial research and drug development.

Cognitive dysfunction and psychopathology: a cohort study of adults with intellectual developmental disorder

BACKGROUND

Cognitive impairment of intellectual developmental disorders (IDD) is determined by several different combinations of specific cognitive alterations. People with IDD present a rate of mental health problems that is up to 4 times higher than that of the general population. Despite this, the relationship between specific cognitive dysfunctions and co-occurring mental disorders has not been adequately studied. The aim of the present paper is to investigate the association between specific cognitive dysfunctions and specific psychiatric symptoms and syndromes in people with IDD.

METHODS

One hundred and twenty adults with mild to moderate IDD living in residential facilities underwent a clinical and instrumental assessment for specific cognitive and psychopathological features.

RESULTS

Participants with IDD and ASD have significantly lower scores compared to those without respect to who has not the diagnosis on the Processing Speed Index (PSI) and Perceptual Reasoning Index (PRI) on the WAIS-IV and higher time scores on the TMT A. Moreover, there is a significant association between years of hospitalisation and TMT B and TMT B A time scores; the longer a participant with IDD was hospitalised, the worse their performance on the TMT. Although not statistically significant, many psychopathological clusters showed substantial cognitive profiles.

CONCLUSIONS

Although further research is needed, neuropsychological and IQ tests scores seem to be differently associated to various psychopathological conditions co-occurring with IDD, and with ASD especially. Cognitive assessment seems to support diagnosis and treatment of psychopathological co-occurrences in persons with IDD, also in consideration of indirect implications including a better knowledge of the patient's characteristics beyond IQ deficit.

HPV self-sampling acceptability among women in Italy: preliminary results of a cross-sectional study

Background

Secondary prevention measures have strongly contributed to the reduction of incidence and mortality of cervical cancer (CC) identifying women at high risk of developing it. This cross-sectional study aimed to investigate the acceptability of a home-based self-sampling methodology for Human Papilloma Virus (HPV) testing and the factors that may influence women’s preference.

Methods

A random sample of women over the age of 50 years has been selected in Southern part of Italy. Data was collected through an anonymous self-administered questionnaire and included socio-demographic characteristics, knowledge of HPV infection and prevention measures, and attitudes towards the acceptability of self-collected cervico-vaginal sampling (CVS) and urine sampling (US).

Results

Among the 321 women who completed the survey, more than two-thirds (73.7%) knew that CC is caused by HPV, only 68.9% knew that the HPV screening is useful for an early detection and diagnosis of CC, and 17% never had Pap-test or HPV-DNA test. Of the respondents, 67.9% declared that they preferred self-collected US for future HPV testing compared with clinician-taken cervical samples (CCS). The most common reasons reported for preferring US included that it was easier (54.8%), more convenient (28.7%), and less embarrassing (21.7%). Among those women who showed negative attitude towards self-collected US, 8 out of 10 (77.3%) expressed scepticism about its diagnostic performance. Only 37% of the sample preferred CVS, and this attitude is mainly attributable to the fear of not carrying out a correct self-sampling (71.2%) and to its underrated diagnostic performance (33.7%).

Conclusions

The preliminary results suggest that US is more acceptable than CCS and CVS in Italy. Urinary HPV test presents similar accuracy of the latter tests to detect CC and its supply in the context of population-based screening programmes could improve adherence, reducing the cost and burden on physicians.

Key messages

• Urine self-sampling could represent an innovative early detection approach to increase adherence to cervical cancer screening programmes.

• Further research is needed to assess whether the screening status and the strategy of self-samplers distribution could act as predictors of screening uptake.

Preventing food contamination: preliminary results of a cross-sectional study among food handlers

Background

More than 600 million people around the world get sick every year due to eating contaminated food, which is impressive considering that all foodborne diseases (FDs) are preventable. Contamination during food preparation by food handlers (FHs) is one of the main causes of FDs. The aim of this study is to assess the knowledge and behaviors of FHs related to FDs.

Methods

The cross-sectional study was conducted in two regions (i.e. Calabria and Sicily) of Southern Italy. Data was collected through an anonymous self-administered questionnaire designed to retrieve sociodemographic information, knowledge about food safety, and food-handling behaviors among a randomly selected sample of FHs ≥ 18 years of age.

Results

Findings refer to a sample of 171 respondents with a mean age of 40 years (SD ± 12.7). A vast majority (63.7%) of FHs did not know the correct procedure for hand washing according to Food & Drug Administration (FDA) guidelines and 28.4% of subjects did not wash their hands after touching raw food, which constitutes a major risk of food cross-contamination. One-third of FHs were unknowledgeable that cross-contamination (e.g. using the same utensils for cooked and raw foods) could lead to FDs. Multiple logistic regression analysis showed a positive correlation (p &lt; 0.001) among good knowledge and proper food-handling practices, such as using separate kitchen utensils to prepare cooked and raw foods and storing them in separate areas or fridges. Less than half of the sample (42.1%) reported the need for more information about FDs.

Conclusions

Preliminary results highlight a lack of knowledge about simple rules to avoid food cross-contamination that could negatively impact on food safety and food-handling behaviors. This study add evidence about areas where intervention are needed to reduce the occurrence of FDs.

Key messages

Flu immunization during pregnancy: a cross-sectional study among Italian healthcare providers

Background

Flu vaccination during pregnancy has been proven to be effective in preventing illness and hospitalization in both pregnant women and newborns. However, flu vaccination uptake is still suboptimal. The study aimed to assess if healthcare providers (HCPs) are knowledgeable about flu vaccination recommendation during pregnancy and if they routinely recommend the vaccination.

Methods

The present survey was carried out among obstetricians-gynaecologists (OBs), midwives and primary care physicians (PCPs) in the Southern part of Italy. Data were collected through an anonymous self-administered questionnaire that included professional information, knowledge, perceptions and practices on flu vaccination during pregnancy.

Results

96 participants were hitherto enrolled (36.5% OBs, 35.4% PCPs and 28.1% midwives). Among the responders, 63.5% and 66.7% knew that flu vaccination can be administrated during any trimester of pregnancy and reduces the risk of preterm birth and miscarriage, respectively. Alarmingly, more than a fifth (22.9%) of the sample believed that vaccines during pregnancy are more dangerous than safe and only 67.7% routinely recommend the flu vaccine to all women regardless of their stage in pregnancy. Among HCPs who did not recommend the flu shot, the most frequently reported reasons were that flu vaccine recommendation was outside the scope of their practice (62.5%), that women are more hesitant about vaccines during pregnancy (37.5%) and lack of time (25%).

Conclusions

The preliminary results highlight alarming gaps in knowledge (e.g. immunization timing) and suboptimal routine recommendation of the flu vaccine that represents a missed opportunity. Indeed, it has been demonstrated that when women are offered vaccination, most tend to accept it.

Key messages

• Unmotivated concerns about vaccine safety during pregnancy have to be addressed among HCPs to enhance flu recommendation and, subsequently, immunization coverage in pregnant women.

• Strategies to disseminate evidence-based recommendations to HCPs regarding flu immunization during pregnancy have to be implemented and evaluated in order to improve public health.

Comparison between recommended and mandatory vaccine uptake during adolescence in Italy

Background

Immunization programs are key preventive interventions and have largely contributed to reducing the burden of infectious diseases and decreasing related morbidity, mortality and healthcare costs. The study aimed to investigate coverage regarding diphtheria, tetanus, and acellular pertussis (dTap) - Inactivated Poliomyelitis Vaccine (IPV) and Human Papilloma Virus (HPV) vaccine and attitudes towards vaccinations among undergraduate university students in Southern Italy.

Methods

This cross-sectional study was conducted among 327 students through an anonymous online questionnaire and included socio-demographic characteristics, attitudes towards vaccinations overall and specifically on dTap-IPV and HPV, reasons for having received or not vaccinations and willingness to receive vaccinations.

Results

One third of the students were concerned about serious adverse effects of vaccines and 95% believed that vaccines for uncommon diseases are useless. During adolescence, 89% of the sample received the mandatory dTap-IPV vaccine booster. Among unvaccinated students, 45% were unwilling to get vaccinated against dTap-IPV because they believed not to be at risk of infection (59%) and had lack of recommendation (35.3%). Regarding vaccination against HPV, 67% had received the recommended schedule. Among those who did not receive it, 34% were unwilling to get vaccinated because they did not feel at risk of HPV infection (41%). Interestingly, 16% of the sample disclosed some barriers to access vaccination centers. Moreover, 30% declared that HPV vaccination was discouraged by healthcare professionals (HCPs).

Conclusions

Vaccination uptake is worryingly low and national objective coverage seems not still achieved. Likewise, risk perception of vaccine-preventable diseases was low and it seems negatively impact on the intention to get vaccinated. Improving vaccine confidence among HCPs is crucial as they have been shown to have the potential to influence patient vaccination uptake.

Key messages

Understanding barriers to dTap vaccination recommendations during pregnancy among healthcare workers

Background

Diphtheria, tetanus and pertussis (dTap) vaccination is heavily endorsed during pregnancy. However, maternal dTap immunization rates in Italy remain low. Lack of healthcare workers (HCWs) recommendation to get vaccinated represents one of the main barriers to immunization during pregnancy. Therefore, this study aimed to investigate what HCWs know about dTap vaccination, practices and potential barrier to recommending immunization during pregnancy.

Methods

This cross-sectional study was conducted among obstetricians-gynaecologists (OBs), midwives and general practitioners (GPs) in 2 regions of Southern Italy. An anonymous self-administered questionnaire was used to collect data on professional information, knowledge, risk perceptions and practices regarding dTap vaccination during pregnancy.

Results

Until now 94 HCWs were recruited (36.2% OBs, 35.1% GPs and 28.7% midwives). Overall, 63.8% knew that dTap vaccination has to be administered during the third trimester of gestation and 94.7% that it is able to protect newborns against pertussis before active immunization. One-third of the HCWs believed that vaccines in pregnancy were more dangerous than safe. Seven out of ten HCWs routinely recommended dTap vaccine and provided information about dTap vaccination to all pregnant women. Most frequent reported reasons for not recommending dTap vaccination during pregnancy were that it was outside the scope of their practice (72.4%), that women are more vaccine hesitant during pregnancy (42.9%), lack of time (28.6%), lack of knowledge on the topic (28.6%) and the belief that the vaccine could interfere with the development of the fetus (14,3%).

Conclusions

Lack of knowledge, unsatisfactory recommendation of dTap immunization during pregnancy and uncertainty over their responsibility around vaccination suggest that public health organisations should strengthen dissemination and implementation of evidence-based recommendations.

Key messages

• Barriers to recommending dTap immunization during pregnancy remain among healthcare workers.

• Strategies (e.g. electronic reminders) to facilitate HCWs in recommending and informing on dTap immunization should be implemented and evaluated to improve vaccination coverage in pregnant women.

Patients with resolution of low-lying placenta and placenta previa remain at increased risk of postpartum hemorrhage

OBJECTIVE

To determine whether women who experience resolution of low placentation (low-lying placenta or placenta previa) are at increased risk of postpartum hemorrhage compared to those with normal placentation throughout pregnancy.

METHODS

This was a retrospective cohort study of women who delivered at Mount Sinai Hospital between 2015 and 2019, and who were diagnosed with low-lying placenta or placenta previa on transvaginal ultrasound at the time of the second-trimester anatomical survey, with resolution of low placentation on subsequent ultrasound examination. Women undergoing second-trimester anatomical survey who had normal placentation on transvaginal ultrasound 3 days before or after the cases were randomly identified for comparison. The primary outcome was the rate of postpartum hemorrhage. Secondary outcomes included the need for a blood transfusion, use of additional uterotonic medication, the need for additional procedures to control bleeding, and maternal admission to the intensive care unit. Outcomes were assessed using a multivariable logistic regression model.

RESULTS

A total of 1256 women were identified for analysis, of whom 628 had resolved low placentation and 628 had normal placentation. Women with resolved low placentation, compared to those with normal placentation throughout pregnancy, had significantly higher mean age (33.0 ± 5.4 years vs 31.9 ± 5.5 years; P < 0.01) and lower mean body mass index at delivery (27.9 ± 5.5 kg/m² vs 30.2 ± 5.7 kg/m² ; P < 0.01), and were more likely to have undergone in-vitro fertilization, be of non-Hispanic white race, have posterior placental location (all P < 0.01) and have private/commercial health insurance (P = 0.04). Patients with resolved low placentation vs normal placentation had greater odds of postpartum hemorrhage (adjusted odds ratio (aOR), 3.5 (95% CI, 2.0-6.0); P < 0.01), use of additional uterotonic medication (aOR, 2.2 (95% CI, 1.5-3.1); P < 0.01) and increased rates of additional procedures to control bleeding (aOR, 4.0 (95% CI, 1.3-11.9); P = 0.01).

CONCLUSION

Despite high rates of resolution of low-lying placenta and placenta previa by term, women with resolved low placentation remain at increased risk of postpartum hemorrhage compared to those with normal placentation throughout pregnancy. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis

BACKGROUND

The choice of inhaler device for asthma patients depends upon multiple attributes. We investigated factors that may drive general practitioners (GPs) and respiratory specialists in the prescription of inhaler devices for asthma patients who initiated inhalation therapy.

METHODS

We retrospectively analysed prescriptions by GPs and respiratory specialists to asthma patients commencing inhaled corticosteroid/long-acting β2-agonist combination therapy available as both pressurised metered-dose inhalers (pMDIs) and dry powder inhalers (DPIs). Patient characteristics were compared by device and multivariate analysis was used to model the likelihood of receiving a pMDI as opposed to a DPI in order to identify drivers for prescription. A sample of the respiratory specialists completed an ad-hoc survey of their perceived success in achieving asthma control in their patients and barriers to attaining full control.

RESULTS

Prescription of a particular inhaler device was unrelated to the characteristics of the patients. Multivariate analysis revealed that the main driver for the choice of inhaler device was the medication (Odds Ratio and 95% Confidence Interval, respectively for GPs and specialists: 0.19 [0.16-0.23]; 0.17 [0.08-0.37]). Specialists perceived asthma as being inadequately controlled in 41% of their patients, and considered patients' difficulties in using DPIs and pMDIs as instrumental in this, citing a need for a novel, more effective inhaler technology.

CONCLUSION

Physicians choose inhaler devices according to the prescribed drugs and not to the characteristics of the individual patient. This may reflect a lack of confidence in existing inhaler devices and underlines the need for technologies, which are more reliable and easier to use by patients.

The Island CGH, a new coding scheme: concept and demonstration

Computer generated holograms (CGHs) are powerful optical elements used in many fields, such as wavefront shaping, quality testing of complex optics, and anti-counterfeiting devices. The Lee algorithm is the most used to generate binary amplitude Fourier holograms. Grayscale CGHs are known to give a higher reconstruction quality than binary holograms, but they usually require a cumbersome production process. A very simple and straightforward method of manufacturing rewritable grayscale CGHs is proposed here by taking advantage of two key components: a digital micro-mirror device (DMDs) and a photochromic plate. An innovative algorithm, named Island algorithm, able to generate grayscale amplitude Fourier CGHs, is reported and compared with the standard Lee approach, based on 9 levels. A crucial advantage lies on the fact that the increase or decrease of the quantification does not affect the spatial resolution. In other words, the new coding leads to a higher spatial resolution (for a given CGH size) and a reconstructed image with an order of magnitude higher contrast with respect to the classical Lee-coded hologram. In order to show the huge potential of our approach, a 201 level Island hologram is designed, produced and reconstructed, pushing the contrast to values higher than10⁴. These results reveal the potential of our process as well as our algorithm for generating programmable grayscale CGHs.

A27 Whole genome characterization of influenza D viruses detected in cattle herds in northern Italy between 2015 and 2017

Influenza D virus (IDV) is a new viral genus identified within the Orthomyxoviridae family, showing 50 per cent amino acid identity with human influenza C virus. Similar to human influenza viruses of the C genus, IDV also harbors 7 genomic segments and uses 9-O-acetylated sialic acids as cell receptors. This newly emerged virus exhibits a broad host range and is capable of infecting swine, cattle, sheep, goats, ferrets, and guinea pigs. In Italy, IDV was first detected in archived samples collected between 2014 and 2015 from cattle and swine in the Po Valley area. Here, we report the genetic characterization of IDV viruses detected in an extensive area of northern Italy, namely Veneto, Lombardy, and Piedmont, through passive surveillance between September 2015 and October 2017. A total of 482 samples, including nasal swabs, lungs, and bronchoalveolar lavage fluid, collected from 309 cattle farms were tested. Thirty cattle herds turned out to be positive, for a total of 40 samples positive by Real Time RT-PCR targeting the PB2 gene. Representative IDV positive swabs were sequenced on an Illumina Miseq platform, and phylogenetic analyses were performed for each genome segment. The analyses of the seven gene segments demonstrated that the viruses identified in the north of Italy clearly grouped within a genetic cluster of IDV sequences previously described in Italy and in the USA, thus suggesting a common origin for these viruses. Interestingly, the IDVs identified in Italy presented a low similarity (96.1% to 98.8% for the seven gene segments) to the French IDVs, which is the only other European country where this pathogen has been identified and characterized so far. The wide IDV host range and the ability of this virus to reassort are a matter of concern. Results of this study indicate that IDV is extensively circulating among bovine herds in Northern Italy and suggest a potential role of IDV in the bovine respiratory disease complex, highlighting the need to perform surveillance on an ongoing basis to track its spread and evolution.

Abstract 4451: Evaluation of the therapeutic potential of phosphine oxide pyrazole inhibitors in tumors harboring EGFR C797S mutation

Osimertinib is a next-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with activity against both the activating and the ‘gatekeeper’ T790M EGFR mutations. An acquired EGFR C797S mutation has been reported to mediate osimertinib resistance in approximately 15% and 7% of patients in second-line and first-line treatment respectively. This percentage in the first-line setting will likely evolve as the first line data mature. The C797S mutation leads to the loss of covalent binding of osimertinib to mutant EGFR. The high affinity of the EGFR triple mutant for ATP presents a challenge for reversible inhibitor design, particularly as the loss of the cysteine at position 797 precludes the previously exploited covalent approaches. We have explored various approaches to address this challenge, including an effort to maximise reversible affinity to target the C797S mutation without requiring a covalent bond. We describe herein the therapeutic potential of reversible phosphine oxide pyrazole inhibitors in tumors harboring C797S.

Using structure-based design, we were able to design a series of phosphine oxide pyrazole inhibitors that displayed exceptionally high biochemical potency against EGFR C797S mutation, which translated into good activity in cell-based assays. Using CRISPR-Cas 9 genome editing technology, we engineered cellular disease-relevant models to express the C797S mutation to evaluate potency in vitro and in vivo.

By modulating the physicochemical properties of our in vitro leads, we were able to achieve good oral exposure of cellularly active EGFR C797S inhibitors such as AZ’7608. We showed that AZ’7608 inhibits signalling pathways and cellular growth of C797S EGFR cell lines in vitro and demonstrated an improved WT EGFR margin. This translated into 52% (p&lt;0.05, at day 14) tumor growth inhibition in vivo when compared to the control group. The efficacy of AZ’7608 is enhanced by its combination with anti-EGFR antibody, showing tumor regression (82%, p&lt;0.001). In addition, we performed pharmacodynamic studies to explore the relationship between efficacy and target/pathway modulation. These studies establish a clear relationship between depth and duration of inhibition of the phosphorylation of EGFR and anti-tumor efficacy.

The work presented herein shows a proof of concept for reversible phosphine oxide pyrazole inhibitors to target tumors harboring C797S. The emergence of the C797S EGFR mutation remains a key area of unmet need and warrants further efforts in drug discovery.

Citation Format: Nicolas Floch, M. Raymond V. Finlay, Ambra Bianco, Sue Bickerton, Nicola Colclough, Darren A. Cross, Emanuela M. Cuomo, Carine M. Guerot, David Hargreaves, Matthew J. Martin, Darren McKerrecher, Daniel J. O’Neill, Jonathan P. Orme, Amar Rahi, Paul D. Smith, Richard A. Ward. Evaluation of the therapeutic potential of phosphine oxide pyrazole inhibitors in tumors harboring EGFR C797S mutation [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4451.

The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement

Adiponectin (Acrp30) plays an important role in energy metabolism and inflammation. Recently, in vivo serum Acrp30 levels have been reported to be correlated to risk of developing several types of cancers such as lung cancer, and in vitro studies have demonstrated a role for Acrp30 in the control of cell proliferation and survival. However, the molecular effects of Acrp30 on lung cancer have not yet been clearly defined. In the present study, we investigated the effects of different concentrations of Acrp30 on the A549 human alveolar epithelial cell line, an in vitro model of lung adenocarcinoma. A549 cells were exposed to various concentrations of Acrp30 and successively, proliferation, apoptosis and oxidative stress were evaluated by MTT test, caspase activity assay, flow-cytometry and western blotting analysis. Our results demonstrated that Acrp30 causes, in a time- and dose-dependent manner, a reduction of cell viability and duplication together with an increase in cell apoptosis rate. In addition, we found that Acrp30 induces an increase of lipid peroxidation evaluated by TBARS assay and a concomitant reduction of nitric oxide release, both markers of cellular oxidative stress. Taken together, our data on A549 cells provides new insight into potential involvement of Acrp30 on physio-pathologic mechanisms of lung diseases through interference with proliferation, apoptosis and oxidative status.